Opin vísindi

Fletta eftir höfundi "Dam, Merete"

Fletta eftir höfundi "Dam, Merete"

Röðun: Raða: Niðurstöður:

  • Icon
    Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia 
    Dam, Merete; Centanni, Maddalena; Friberg, Lena E.; Centanni, Daniel; Karlsson, Mats O.; Stensig Lynggaard, Line; Johannsdottir, Inga Maria; Wik, Hilde Skuterud; Malmros, Johan; Vaitkeviciene, Goda Elizabeta; Griskevicius, Laimonas; Hallböök, Helene; Jónsson, Ólafur Gísli; Overgaard, Ulrik; Schmiegelow, Kjeld; Hansen, Stefan Nygaard; Heyman, Mats; Albertsen, Birgitte Klug (2024)
    Asparaginase is an essential component of acute lymphoblastic leukemia (ALL) therapy, yet its associated toxicities often lead to treatment discontinuation, increasing the risk of relapse. Hypersensitivity reactions include clinical allergies, silent ...
  • Icon
    Sequelae and post-thrombotic syndrome after venous thromboembolism in acute lymphoblastic leukemia survivors treated on the NOPHO ALL2008 protocol 
    Dam, Merete; Lynggaard, Line Stensig; Jónsson, Ólafur Gísli; Saulyte Trakymiene, Sonata; Palk, Katrin; Jarvis, Kirsten; Andrés-Jensen, Liv; Tuckuviene, Ruta; Albertsen, Birgitte Klug (2024-06)
    The treatment of acute lymphoblastic leukemia (ALL) is frequently complicated by toxicity, including venous thromboembolism (VTE) affecting roughly 8% of patients. VTE can lead to post-thrombotic syndrome (PTS), a group of signs and symptoms developed ...